Jamie Mills, MD, PhD
Understanding Metabolic Reprogramming in PDAC Through Dual Inhibition of KRAS and BRD4
This project focuses on BRD4, a protein implicated in regulating cancer growth and metabolism. The team will test combinations of inhibitors for BRD4 and other key pancreatic cancer pathways, and analyze how they change the metabolism and epigenetics of cancer cells and mouse models. The work lays the foundation for testing these combinations in clinical trials.
Dr. Jamie Mills is a medical oncologist at the University of Michigan, specializing in the treatment of pancreatic and other GI cancers, and part of a research team working to translate laboratory findings efficiently into clinical trials. Originally from the San Francisco Bay Area, she studied at California State University, Chico, earned her MD and PhD in cancer biology at the Medical University of South Carolina, and completed her residency in internal medicine and fellowship in hematology and oncology at the University of Michigan.
Seed grants start at $50,000 — awarded by scientists, reported on annually.
Donate →Jamie Mills, MD, PhD
Understanding Metabolic Reprogramming in PDAC Through Dual Inhibition of KRAS and BRD4
This project focuses on BRD4, a protein implicated in regulating cancer growth and metabolism. The team will test combinations of inhibitors for BRD4 and other key pancreatic cancer pathways, and analyze how they change the metabolism and epigenetics of cancer cells and mouse models. The work lays the foundation for testing these combinations in clinical trials.
Dr. Jamie Mills is a medical oncologist at the University of Michigan, specializing in the treatment of pancreatic and other GI cancers, and part of a research team working to translate laboratory findings efficiently into clinical trials. Originally from the San Francisco Bay Area, she studied at California State University, Chico, earned her MD and PhD in cancer biology at the Medical University of South Carolina, and completed her residency in internal medicine and fellowship in hematology and oncology at the University of Michigan.
Seed grants start at $50,000 — awarded by scientists, reported on annually.
Donate →